社区健康工作者主导决策辅导促进黑人男性前列腺癌筛查共同决策的随机试验
本研究在联邦合格健康中心(FQHC)开展随机对照试验,计划纳入228名40-69岁黑人男性及至多15名提供者,比较社区健康工作者(CHW)主导的决策辅导加决策辅助与注意力控制(饮食生活方式互动)对前列腺癌筛查共同决策(SDM)的效果。主要结局为患者决策质量和是否接受PSA筛查的决策,以及提供者对干预的可接受性和可行性,并假设干预将带来偏好一致决策和决策满意度。
要点
- CHW主导决策辅导可能改善黑人男性前列腺癌筛查的决策质量与偏好一致决策。
- 试验同时评估提供者对干预的可接受性和可行性,关注患者-提供者沟通。
- 研究在FQHC开展,按提供者随机并控制年龄分层(40-54岁和55-69岁)。
核心结论
- CHW主导的决策辅导有望促进黑人男性前列腺癌筛查的偏好一致决策和决策满意度,并可能提高医生咨询满意度。
研究设计与样本
- 随机对照试验,计划纳入228名40-69岁黑人男性患者及至多15名提供者,在FQHC开展。
- 患者随机分为CHW决策辅导加决策辅助组或注意力对照组(饮食生活方式互动),按提供者独立随机并按年龄(40-54岁和55-69岁)分层。
- 混合方法:定量使用客观验证量表,定性使用半结构化深度访谈和临床遭遇主题分析。
关键数值与推荐
- 主要结局:患者决策质量和是否接受PSA筛查的决策;提供者干预可接受性和可行性。
- 样本量足以检测主要结局(知识、PSA筛查率差异)的组间差异。
- 概念模型结合预防保健模型(PHM)和知情决策模型。
临床怎么用
- 在初级保健中可考虑由CHW主导决策辅导以促进黑人男性前列腺癌筛查的共同决策。
- 干预需评估可接受性和可行性,并关注患者-提供者沟通质量。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Black men are disproportionately affected by prostate cancer, the most common non-cutaneous malignancy among men in the USA. The United States Preventive Services Task Force (USPSTF) encourages prostate-specific antigen (PSA) testing decisions to be based on shared decision-making (SDM) clinician professional judgment, and patient preferences. However, evidence suggests that SDM is underutilized in clinical practice, especially among the most vulnerable patients. The purpose of this study is to evaluate the efficacy of a community health worker (CHW)-led decision-coaching program to facilitate SDM for prostate cancer screening among Black men in the primary care setting, with the ultimate aim of improving/optimizing decision quality. METHODS: We proposed a CHW-led decision-coaching program to facilitate SDM for prostate cancer screening discussions in Black men at a primary care FQHC. This study enrolled Black men who were patients at the participating clinical site and up to 15 providers who cared for them. We estimated to recruit 228 participants, ages 40-69 to be randomized to either (1) a decision aid along with decision coaching on PSA screening from a CHW or (2) receiving a decision aid along with CHW-led interaction on modifying dietary and lifestyle to serve as an attention control. The independent randomization process was implemented within each provider and we controlled for age by dividing patients into two strata: 40-54 years and 55-69 years. This sample size sufficiently powered the detection differences in the primary study outcomes: knowledge, indicative of decision quality, and differences in PSA screening rates. Primary outcome measures for patients will be decision quality and decision regarding whether to undergo PSA screening. Primary outcome measures for providers will be acceptability and feasibility of the intervention. We will examine how decision coaching about prostate cancer screening impact patient-provider communication. These outcomes will be analyzed quantitatively through objective, validated scales and qualitatively through semi-structured, in-depth interviews, and thematic analysis of clinical encounters. Through a conceptual model combining elements of the Preventative Health Care Model (PHM) and Informed Decision-Making Model, we hypothesize that the prostate cancer screening decision coaching intervention will result in a preference-congruent decision and decisional satisfaction. We also hypothesize that this intervention will improve physician satisfaction with counseling patients about prostate cancer screening. DISCUSSION: Decision coaching is an evidence-based approach to improve decision quality in many clinical contexts, but its efficacy is incompletely explored for PSA screening among Black men in primary care. Our proposal to evaluate a CHW-led decision-coaching program for PSA screening has high potential for scalability and public health impact. Our results will determine the efficacy, cost-effectiveness, and sustainability of a CHW intervention in a community clinic setting in order to inform subsequent widespread dissemination, a critical research area highlighted by USPSTF. TRIAL REGISTRATION: The trial was registered prospectively with the National Institute of Health registry ( www.clinicaltrials.gov ), registration number NCT03726320 , on October 31, 2018.
引用
- Makarov DV, Feuer Z, Ciprut S, et al. Randomized trial of community health worker-led decision coaching to promote shared decision-making for prostate cancer screening among Black male patients and their providers. Trials. 2021. PMID: 33568208. doi:10.1186/s13063-021-05064-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。